<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-65GOQJ4F</identifier><date>2018</date><creator>Bulur, Işil</creator><relation>documents/doc/6/URN_NBN_SI_doc-65GOQJ4F_001.pdf</relation><relation>documents/doc/6/URN_NBN_SI_doc-65GOQJ4F_001.txt</relation><format format_type="volume">27</format><format format_type="type">article</format><format format_type="issue">iss. 3</format><format format_type="extent">str. 121-126</format><identifier identifier_type="ISSN">1318-4458</identifier><identifier identifier_type="COBISSID">305094400</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-65GOQJ4F</identifier><language>eng</language><publisher>Slovene Welding Society</publisher><source>Acta dermatovenerologica Alpina, Pannonica et Adriatica</source><rights>InC</rights><subject language_type_id="slv">dermatologija</subject><subject language_type_id="slv">kožne bolezni</subject><subject language_type_id="slv">omalizumab</subject><subject language_type_id="slv">urtikarija</subject><subject language_type_id="slv">zdravljenje</subject><title>real-life experience in Turkey</title><title>The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria</title></Record>